In 2006 Dr. Martin Yaffe’s lab at Sunnybrook Research Institute developed a new way of preparing whole-mount sections of breast tissue, which opened up the exciting possibility of correlating pathology directly with medical imaging. However, the huge images that were produced posed a significant challenge to researchers; existing software for viewing images was either incapable of handling the large multi-scale images or it was too expensive and inflexible. To address these issues, Dr. Anne Martel, currently Chief Scientific Officer and co-founder of Pathcore, developed a new technology with funding assistance from OICR.
Pathcore was created in order develop an integrated pathology platform that could support the needs of both researchers and clinicians…
“We were fortunate enough to obtain funding from what is now called OICR’s Imaging Translation Program, a program that encourages research groups to collaborate and to build tools that could accelerate the rate of new discoveries in cancer research,” explains Martel. “This led to the development of the Sedeen Viewer, which was specifically designed to meet the needs of cancer researchers. Pathcore was created in order develop an integrated pathology platform that could support the needs of both researchers and clinicians and provide a translational pathway for new diagnostic tools.”
You can read more about Pathcore and the recent investment by the National Cancer Institute in the story below:
National Cancer Institute invests $4 million in U of T-based startup Pathcore
From University of Toronto News